XML 26 R7.htm IDEA: XBRL DOCUMENT v3.22.4
EPT - Consolidated Statements of Equity - USD ($)
shares in Thousands, $ in Thousands
Total
Cumulative Effect, Period of Adoption, Adjustment
Common stock
Additional paid-in capital
Distributions in excess of accumulated earnings
Distributions in excess of accumulated earnings
Cumulative Effect, Period of Adoption, Adjustment
Accumulated other comprehensive income (loss), net
Noncontrolling interest
Issuance of common stock under:                
Cumulative effect upon adoption $ 6,403,504 $ (190) $ 7 $ 7,121,927 $ (887,619) $ (190) $ (13,888) $ 183,077
Balance at period beginning (in shares) at Dec. 31, 2019     66,092          
Balance at period beginning at Dec. 31, 2019 6,403,504 $ (190) $ 7 7,121,927 (887,619) $ (190) (13,888) 183,077
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net income 599,332       568,870     30,462
Reversal of unrealized gains upon the sale of marketable debt securities 0              
Cash flow hedge losses reclassified to earnings 3,338           3,225 113
Change in fair value of derivatives and amortization of swap settlements (4,148)           (4,007) (141)
Change in fair value of marketable debt securities, net (61)           (59) (2)
Issuance of common stock under:                
Stock option and restricted stock plans, net (in shares)     95          
Stock option and restricted stock plans, net 9,201     9,201        
Sale of common stock, net (296)     (296)        
Equity based compensation costs 12,913     12,453       460
Retirement of common stock, net (in shares)     (1,197)          
Retirement of common stock, net (269,315)   $ (1) (269,314)        
Changes in the redemption value of redeemable noncontrolling interest 4,299     4,375       (76)
Changes in noncontrolling interest from acquisition 1,349             1,349
Distributions to noncontrolling interest (31,367)             (31,367)
Redemptions of noncontrolling interest (in shares)     (9)          
Redemptions of noncontrolling interest (3,113)     (2,020)       (1,093)
Common stock dividends (542,254)       (542,254)      
Balance at period end (in shares) at Dec. 31, 2020     64,999          
Balance at period end at Dec. 31, 2020 6,183,192   $ 6 6,876,326 (861,193)   (14,729) 182,782
Issuance of common stock under:                
Cumulative effect upon adoption 6,183,192   $ 6 6,876,326 (861,193)   (14,729) 182,782
Net income 515,691       488,554     27,137
Reversal of unrealized gains upon the sale of marketable debt securities 0              
Cash flow hedge losses reclassified to earnings 0              
Change in fair value of derivatives and amortization of swap settlements 9,170           8,859 311
Change in fair value of marketable debt securities, net 329           318 11
Stock option and restricted stock plans, net (in shares)     279          
Stock option and restricted stock plans, net 53,052   $ 1 53,051        
Sale of common stock, net (455)     (455)        
Equity based compensation costs 11,683     11,286       397
Retirement of common stock, net (in shares)     (40)          
Retirement of common stock, net (9,172)     (9,172)        
Changes in the redemption value of redeemable noncontrolling interest (6,890)     (7,489)       599
Contributions from noncontrolling interest 1,900             1,900
Distributions to noncontrolling interest (29,341)             (29,341)
Redemptions of noncontrolling interest (in shares)     10          
Redemptions of noncontrolling interest (8,457)     (7,566)       (891)
Common stock dividends (544,194)       (544,194)      
Balance at period end (in shares) at Dec. 31, 2021     65,248          
Balance at period end at Dec. 31, 2021 6,176,508   $ 7 6,915,981 (916,833)   (5,552) 182,905
Issuance of common stock under:                
Cumulative effect upon adoption 6,176,508   $ 7 6,915,981 (916,833)   (5,552) 182,905
Net income 432,985       408,315     24,670
Reversal of unrealized gains upon the sale of marketable debt securities (577)           (557) (20)
Cash flow hedge losses reclassified to earnings 0              
Change in fair value of derivatives and amortization of swap settlements 54,158           52,351 1,807
Change in fair value of marketable debt securities, net 233           224 9
Stock option and restricted stock plans, net (in shares)     89          
Stock option and restricted stock plans, net 17,309     17,309        
Sale of common stock, net (314)     (314)        
Equity based compensation costs 11,446     11,059       387
Retirement of common stock, net (in shares)     (740)          
Retirement of common stock, net (189,726)   $ (1) (189,725)        
Changes in the redemption value of redeemable noncontrolling interest 7,038     6,230       808
Contributions from noncontrolling interest 125             125
Distributions to noncontrolling interest (30,959)             (30,959)
Redemptions of noncontrolling interest (in shares)     8          
Redemptions of noncontrolling interest (11,452)     (10,464)       (988)
Common stock dividends (571,658)       (571,658)      
Balance at period end (in shares) at Dec. 31, 2022     64,605          
Balance at period end at Dec. 31, 2022 5,895,116   $ 6 6,750,076 (1,080,176)   46,466 178,744
Issuance of common stock under:                
Cumulative effect upon adoption $ 5,895,116   $ 6 $ 6,750,076 $ (1,080,176)   $ 46,466 $ 178,744